These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3513818)

  • 1. Successful haploidentical mismatched bone marrow transplantation in severe combined immunodeficiency: T cell removal using CAMPATH-I monoclonal antibody and E-rosetting.
    Morgan G; Linch DC; Knott LT; Davies EG; Sieff C; Chessells JM; Hale G; Waldmann H; Levinsky RJ
    Br J Haematol; 1986 Mar; 62(3):421-30. PubMed ID: 3513818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of graft failure by an anti-HLFA-1 monoclonal antibody in HLA-mismatched bone-marrow transplantation.
    Fischer A; Griscelli C; Blanche S; Le Deist F; Veber F; Lopez M; Delaage M; Olive D; Mawas C; Janossy G
    Lancet; 1986 Nov; 2(8515):1058-61. PubMed ID: 2877223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreconstitution in severe combined immunodeficiency after transplantation of HLA-haploidentical, T-cell-depleted bone marrow.
    Friedrich W; Goldmann SF; Vetter U; Fliedner TM; Heymer B; Peter HH; Reisner Y; Kleihauer E
    Lancet; 1984 Apr; 1(8380):761-4. PubMed ID: 6143084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-haploidentical bone marrow transplantation for severe combined immunodeficiency using E rosette fractionation and cyclosporine.
    Fischer A; Durandy A; de Villartay JP; Vilmer E; Le Deist F; Gérota I; Griscelli C
    Blood; 1986 Feb; 67(2):444-9. PubMed ID: 3510681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency.
    Reinherz EL; Geha R; Rappeport JM; Wilson M; Penta AC; Hussey RE; Fitzgerald KA; Daley JF; Levine H; Rosen FS; Schlossman SF
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6047-51. PubMed ID: 6764536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haploidentical bone marrow transplantation for severe combined immunodeficiency disease using soybean agglutinin-negative, T-depleted marrow cells.
    Cowan MJ; Wara DW; Weintrub PS; Pabst H; Ammann AJ
    J Clin Immunol; 1985 Nov; 5(6):370-6. PubMed ID: 3910675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.
    Buckley RH; Schiff SE; Sampson HA; Schiff RI; Markert ML; Knutsen AP; Hershfield MS; Huang AT; Mickey GH; Ward FE
    J Immunol; 1986 Apr; 136(7):2398-407. PubMed ID: 2869085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution of T- and B-cell function after T-lymphocyte-depleted haploidentical bone marrow transplantation in severe combined immunodeficiency due to adenosine deaminase deficiency.
    Silber GM; Winkelstein JA; Moen RC; Horowitz SD; Trigg M; Hong R
    Clin Immunol Immunopathol; 1987 Sep; 44(3):317-20. PubMed ID: 3304740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of multiple monoclonal serum immunoglobulins (multiclonal gammopathy) following both HLA-identical unfractionated and T cell-depleted haploidentical bone marrow transplantation in severe combined immunodeficiency.
    Kent EF; Crawford J; Cohen HJ; Buckley RH
    J Clin Immunol; 1990 Mar; 10(2):106-14. PubMed ID: 2338452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe combined immunodeficiency: treatment by bone marrow transplantation in 15 infants using HLA-haploidentical donors.
    Friedrich W; Goldmann SF; Ebell W; Blütters-Sawatzki R; Gaedicke G; Raghavachar A; Peter HH; Belohradsky B; Kreth W; Kubanek B
    Eur J Pediatr; 1985 Jul; 144(2):125-30. PubMed ID: 3899661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells.
    Reisner Y; Kapoor N; Kirkpatrick D; Pollack MS; Cunningham-Rundles S; Dupont B; Hodes MZ; Good RA; O'Reilly RJ
    Blood; 1983 Feb; 61(2):341-8. PubMed ID: 6217853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic and proliferative T-cell clones with antidonor reactivity from a patient transplanted for severe combined immunodeficiency disease.
    Keever CA; Flomenberg N; Gazzola MV; Pekle K; Yang SY; Small TN; Collins NH; O'Reilly RJ
    Hum Immunol; 1990 Sep; 29(1):42-55. PubMed ID: 2211189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymus and B cell reconstitution in severe combined immunodeficiency after transplantation of monoclonal antibody depleted parental mismatched bone marrow.
    Hong R; Horowitz S; Moen R; Trigg M; Sondel P; Billing R; Borcherding W; Johnson JP; Kanoff M; Bias WB
    Bone Marrow Transplant; 1987 Apr; 1(4):405-9. PubMed ID: 3332148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic reconstitution after haploidentical bone marrow transplantation for immune deficiency disorders: treatment of bone marrow cells with monoclonal antibody CT-2 and complement.
    Moen RC; Horowitz SD; Sondel PM; Borcherding WR; Trigg ME; Billing R; Hong R
    Blood; 1987 Sep; 70(3):664-9. PubMed ID: 3304460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency.
    Pollack MS; Kirkpatrick D; Kapoor N; Dupont B; O'Reilly RJ
    N Engl J Med; 1982 Sep; 307(11):662-6. PubMed ID: 7050708
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe combined immunodeficiency with natural killer-cell predominance: abrogation of graft-versus-host disease and immunologic reconstitution with HLA-identical bone marrow cells.
    Sindel LJ; Buckley RH; Schiff SE; Ward FE; Mickey GH; Huang AT; Naspitz C; Koren H
    J Allergy Clin Immunol; 1984 Jun; 73(6):829-36. PubMed ID: 6233355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-treated bone marrow transplantation for patients with severe combined immune deficiency.
    Parkman R
    Clin Immunol Immunopathol; 1986 Jul; 40(1):142-6. PubMed ID: 3521967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of tolerance associated with disappearance of B cells in a patient sequentially transplanted with paternal and maternal bone marrow for the treatment of severe combined immunodeficiency disease.
    Keever CA; Flomenberg N; Small T; Brochstein J; Collins N; Young-Yang S; Insel R; Dupont B; O'Reilly RJ
    Hum Immunol; 1989 Sep; 26(1):27-38. PubMed ID: 2528525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro T cell depletion using Campath 1M for mismatched BMT for severe combined immunodeficiency (SCID).
    Dickinson AM; Reid MM; Abinun M; Peak J; Brigham K; Dunn J; Cant AJ
    Bone Marrow Transplant; 1997 Feb; 19(4):323-9. PubMed ID: 9051241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.